Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma.
2003-01-01 Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P.
In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease.
2003-01-01 Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P.
Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine.
2003-01-01 Lucesole, M; Poloni, Antonella; Capelli, D; Montanari, M; Cecchi, S; Spitaleri, L; Gini, G; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio
Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease
2004-01-01 Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R.
Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
2004-01-01 Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P.
Combination thalidomide, doxil and dexamethasone as salvage therapy for patients relapsed after tandem autotransplant
2004-01-01 Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Mele, A; Galieni, P; Centurioni, R; Alesiani, F; Candela, M; Leoni, Pietro
Salvage treatment with pegylated liposomal doxorubicin (Caelyx), cyclophosphamide-rituximab (DC-R) plus GM-CSF in B-diffuse large cell lymphoma (B-DLCL) after autologous stem cell transplantation failure
2004-01-01 Olivieri, Attilio; Montanari, M; Spitaleri, L; Capelli, D; Lucesole, M; Scortechini, I; Offidani, M; Gini, G; Troiani, E; Leoni, Pietro
Reduced-intensity conditioning followed by allografting in patients with advanced haematological malignancies older than 60 years
2004-01-01 Olivieri, Attilio; Lucesole, M; Cecchi, S; Dodero, A; Ciceri, F; Bregni, M; Tarella, C; Falda, M; Locasciulli, A; Scime, R; Patriarca, F; Casini, M; Bacigalupo, A; Corradini, P.
Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS: a prospective study from GITMO
2004-01-01 Alessandrino, Ep; La Nasa, G; Malcovati, L; De Fabritiis, P; Bregni, M; Mazza, P; Di Bartolomeo, P; Locasciulli, A; Scime, R; Mordini, N; Olivieri, Attilio; Deliliers, Gl; Bacigalupo, A.
Autologous transplant in over 60 patients with lymphoproliferative disorders: a single-centre experience in 63 patients
2004-01-01 Capelli, D; Olivieri, Attilio; Scortechini, A; Montanari, M; Lucesole, M; Brunori, M; Troiani, E; Gini, G; Masia, M; Pasquini, R; Balducci, F; Leoni, Pietro
Molecular monitoring of minimal residual disease after reduced-intensity conditioning and allogeneic stem cell transplantation in relapsed chronic lymphocytic leukaemia
2004-01-01 Farina, L; Soligo, D; Rizzo, E; Dodero, A; Locasciulli, A; Scime, R; Santoro, A; Gianni, Am; Tarella, C; Lucesole, M; Olivieri, Attilio; Corradini, P.
Reduced-intensity conditioning followed by allogeneic transplantation: poor outcome in secondary versus de novo acute myeloid leukaemias
2004-01-01 Corradini, P; Milani, R; Dodero, A; Tarella, C; Bandini, G; Locasciulli, A; Bernardi, M; Lucesole, M; Busca, A; Soligo, D; Gianni, Am; Bregni, M; Olivieri, Attilio
Effect of age and previous autologous transplant on treatment-related mortality and GVHD in 140 patients treated with reduce-intensity conditioning and allograft for advanced hematological malignancies.
2004-01-01 Corradini, P; Zallio, F; Mariotti, J; Valagussa, P; Dodero, A; Bregni, M; Ciceri, F; Bacigalupo, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio
Effect of age and previous autologous transplantation on treatment-related mortality and graft-versus-host disease in 110 patients treated with reduced-intensity conditioning and allografting for advanced haematological malignancies
2004-01-01 Corradini, P; Zallio, F; Mariotti, J; Bregni, M; Ciceri, F; Bacigalupo, A; Dodero, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Majolino, I; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio
High dose chemotherapy (HD CHT) followed by autologous PBPC transplant in elderly ANLL patients.
2004-01-01 Capelli, D; Troiani, E; Discepoli, G; Poloni, Antonella; Montanari, M; Catarini, M; Centurioni, R; Alesiani, F; Brunori, M; Lucesole, M; Leoni, Pietro; Olivieri, Attilio
Molecular remission can be attained in relapsed or refractory chronic lymphocytic leukemia (CLL) and follicular lymphomas after reduced intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT).
2004-01-01 Farina, L; Carrabba, M; Dodero, A; Rizzo, E; Zorzan, E; Ciceri, F; Locasciulli, A; Olivieri, Attilio; Rambaldi, A; Tarella, C; Santoro, A; Patriarca, F; Bacigalupo, A; Corradini, P.
Reduced-intensity conditioning (RIC) followed by allogeneic transplantation in relapsed lymphomas: Evidence for Graft-Versus-Lymphoma effect in low and high grade histologies, but not in Hodgkin disease
2004-01-01 Corradini, P; Dodero, A; Bregni, M; Olivieri, Attilio; Farina, L; Rizzo, E; Milni, R; Scime, R; Rambaldi, A; Bonifazi, F; Patriarca, F; Locasciulli, A; Bacigalupo, A; Gianni, Am; Tarella, C.
Early discharge ASCT programme in 68 patients with lymphoproliferative disorders: a single-centre experience
2005-01-01 Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Poloni, Antonella; Gini, G; Re, R; Trappolini, S; Pasquini, R; Del Borrello, S; Leoni, Pietro
Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma
2005-01-01 Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; Bregni, M; De Fabritiis, P; Musso, M; Corradini, P.
Reduced-intensity thiotepa based conditioning and rabbit anti-thymocyte globulin for alternative donor transplants: a prospective GITMO trial
2005-01-01 Lamparelli, T; Fanin, R; Bandini, G; Raimondi, R; Faida, M; Scime, R; Bruno, B; Olivieri, Attilio; Alessandrino, Ap; Corradini, P; Ciceri, F; Di Bartolomeo, P; Sacchi, N; Pollicheni, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma. | 1-gen-2003 | Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P. | |
| In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease. | 1-gen-2003 | Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P. | |
| Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine. | 1-gen-2003 | Lucesole, M; Poloni, Antonella; Capelli, D; Montanari, M; Cecchi, S; Spitaleri, L; Gini, G; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio | |
| Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease | 1-gen-2004 | Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R. | |
| Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma | 1-gen-2004 | Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P. | |
| Combination thalidomide, doxil and dexamethasone as salvage therapy for patients relapsed after tandem autotransplant | 1-gen-2004 | Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Mele, A; Galieni, P; Centurioni, R; Alesiani, F; Candela, M; Leoni, Pietro | |
| Salvage treatment with pegylated liposomal doxorubicin (Caelyx), cyclophosphamide-rituximab (DC-R) plus GM-CSF in B-diffuse large cell lymphoma (B-DLCL) after autologous stem cell transplantation failure | 1-gen-2004 | Olivieri, Attilio; Montanari, M; Spitaleri, L; Capelli, D; Lucesole, M; Scortechini, I; Offidani, M; Gini, G; Troiani, E; Leoni, Pietro | |
| Reduced-intensity conditioning followed by allografting in patients with advanced haematological malignancies older than 60 years | 1-gen-2004 | Olivieri, Attilio; Lucesole, M; Cecchi, S; Dodero, A; Ciceri, F; Bregni, M; Tarella, C; Falda, M; Locasciulli, A; Scime, R; Patriarca, F; Casini, M; Bacigalupo, A; Corradini, P. | |
| Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS: a prospective study from GITMO | 1-gen-2004 | Alessandrino, Ep; La Nasa, G; Malcovati, L; De Fabritiis, P; Bregni, M; Mazza, P; Di Bartolomeo, P; Locasciulli, A; Scime, R; Mordini, N; Olivieri, Attilio; Deliliers, Gl; Bacigalupo, A. | |
| Autologous transplant in over 60 patients with lymphoproliferative disorders: a single-centre experience in 63 patients | 1-gen-2004 | Capelli, D; Olivieri, Attilio; Scortechini, A; Montanari, M; Lucesole, M; Brunori, M; Troiani, E; Gini, G; Masia, M; Pasquini, R; Balducci, F; Leoni, Pietro | |
| Molecular monitoring of minimal residual disease after reduced-intensity conditioning and allogeneic stem cell transplantation in relapsed chronic lymphocytic leukaemia | 1-gen-2004 | Farina, L; Soligo, D; Rizzo, E; Dodero, A; Locasciulli, A; Scime, R; Santoro, A; Gianni, Am; Tarella, C; Lucesole, M; Olivieri, Attilio; Corradini, P. | |
| Reduced-intensity conditioning followed by allogeneic transplantation: poor outcome in secondary versus de novo acute myeloid leukaemias | 1-gen-2004 | Corradini, P; Milani, R; Dodero, A; Tarella, C; Bandini, G; Locasciulli, A; Bernardi, M; Lucesole, M; Busca, A; Soligo, D; Gianni, Am; Bregni, M; Olivieri, Attilio | |
| Effect of age and previous autologous transplant on treatment-related mortality and GVHD in 140 patients treated with reduce-intensity conditioning and allograft for advanced hematological malignancies. | 1-gen-2004 | Corradini, P; Zallio, F; Mariotti, J; Valagussa, P; Dodero, A; Bregni, M; Ciceri, F; Bacigalupo, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio | |
| Effect of age and previous autologous transplantation on treatment-related mortality and graft-versus-host disease in 110 patients treated with reduced-intensity conditioning and allografting for advanced haematological malignancies | 1-gen-2004 | Corradini, P; Zallio, F; Mariotti, J; Bregni, M; Ciceri, F; Bacigalupo, A; Dodero, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Majolino, I; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio | |
| High dose chemotherapy (HD CHT) followed by autologous PBPC transplant in elderly ANLL patients. | 1-gen-2004 | Capelli, D; Troiani, E; Discepoli, G; Poloni, Antonella; Montanari, M; Catarini, M; Centurioni, R; Alesiani, F; Brunori, M; Lucesole, M; Leoni, Pietro; Olivieri, Attilio | |
| Molecular remission can be attained in relapsed or refractory chronic lymphocytic leukemia (CLL) and follicular lymphomas after reduced intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT). | 1-gen-2004 | Farina, L; Carrabba, M; Dodero, A; Rizzo, E; Zorzan, E; Ciceri, F; Locasciulli, A; Olivieri, Attilio; Rambaldi, A; Tarella, C; Santoro, A; Patriarca, F; Bacigalupo, A; Corradini, P. | |
| Reduced-intensity conditioning (RIC) followed by allogeneic transplantation in relapsed lymphomas: Evidence for Graft-Versus-Lymphoma effect in low and high grade histologies, but not in Hodgkin disease | 1-gen-2004 | Corradini, P; Dodero, A; Bregni, M; Olivieri, Attilio; Farina, L; Rizzo, E; Milni, R; Scime, R; Rambaldi, A; Bonifazi, F; Patriarca, F; Locasciulli, A; Bacigalupo, A; Gianni, Am; Tarella, C. | |
| Early discharge ASCT programme in 68 patients with lymphoproliferative disorders: a single-centre experience | 1-gen-2005 | Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Poloni, Antonella; Gini, G; Re, R; Trappolini, S; Pasquini, R; Del Borrello, S; Leoni, Pietro | |
| Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma | 1-gen-2005 | Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; Bregni, M; De Fabritiis, P; Musso, M; Corradini, P. | |
| Reduced-intensity thiotepa based conditioning and rabbit anti-thymocyte globulin for alternative donor transplants: a prospective GITMO trial | 1-gen-2005 | Lamparelli, T; Fanin, R; Bandini, G; Raimondi, R; Faida, M; Scime, R; Bruno, B; Olivieri, Attilio; Alessandrino, Ap; Corradini, P; Ciceri, F; Di Bartolomeo, P; Sacchi, N; Pollicheni, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1479
Data di pubblicazione
- 2020 - 202685
- 2010 - 2019662
- 2000 - 2009566
- 1990 - 1999141
- 1981 - 198925
Editore
- BMJ / British Medical Journal Pub...1
- CSIRO Publishing:150 Oxford Stree...1
- Elsevier1
- Elsevier Science Limited:Oxford F...1
- Mary Ann Liebert Incorporated:2 M...1
- Oxford University Press:Journals ...1
- Parthenon Publishing:Richmond Hou...1
Rivista
- NEUROLOGICAL SCIENCES137
- BLOOD94
- BONE MARROW TRANSPLANTATION62
- HAEMATOLOGICA46
- ANNALS OF THE RHEUMATIC DISEASES43
- ITALIAN JOURNAL OF ANATOMY AND EM...40
- ANTICANCER RESEARCH33
- ITALIAN JOURNAL OF BIOCHEMISTRY31
- ACTA OPHTHALMOLOGICA27
- BIOCHIMICA CLINICA25
Keyword
- DBS4
- mortar3
- STN3
- brick2
- DBS STN2
- geopolymer2
- IAQ2
- language disorders2
- mechanical properties2
- P3002
Lingua
- eng955
- ita108
- ger1
- spa1
Accesso al fulltext
- no fulltext1477
- open1
- reserved1